High-dose Simvastatin for Aneurysmal Subarachnoid Haemorrhage
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 255 participants.
Also called NCT01077206
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose prevention
- Phase
- Phase 2/3
- Enrolled
- 255 participants
- Registry
-
NCT01077206
-
- Other papers using this trial's data
- High-dose simvastatin for aneurysmal subarachnoid hemorrhage: multicenter randomized controlled double-blinded clinical trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT01077206. Randomized; triple masking; primary purpose prevention. Start 2010-09 (registry gives no type); primary completion 2013-06 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- High-dose Simvastatin for Aneurysmal Subarachnoid Haemorrhage
- Acronym
- HDS-SAH
- Condition
- Subarachnoid Hemorrhage
- Intervention (Drug)
- Simvastatin
- Lead sponsor
- Chinese University of Hong Kong
- Collaborator
- Hong Kong Government
Record details
- Record id
cardio:ct-nct01077206- Content hash
fdd60cb9a8cb404eb860179ebeb389ced84ddd006e3273eab7eb5424cbea1126